Docking analysis and the possibility of prediction efficacy for an anti-il-13 biopharmaceutical treatment with tralokinumab and lebrikizumab for bronchial asthma

HIGHLIGHTS

• who: Yutaka Nakamura et al. from the Japan, Division of Medical informatics and Bioinformatics, Kobe University Graduate School of have published the article: Docking analysis and the possibility of prediction efficacy for an anti-IL-13 biopharmaceutical treatment with tralokinumab and lebrikizumab for bronchial asthma, in the Journal: PLOS ONE | https://doi.org/10.1371/journal.pone [0188407]. November 20, 2017 of November/20,/2017
• what: The aim of this study was to investigate the prediction efficacy of the anti-IL-13 monoclonal antibodies tralokinumab and lebrikizumab in asthmatic patients with IL-13R144 and IL . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.